Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Antihypertensive effects once-daily fosinopril in patients with essential hypertension

Kim SI, Kwak IS, Rha HY

  • KMID: 1694487
  • Korean J Nephrol.
  • 1993 Dec;12(4):616-620.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Study on the Antihypertensive Effect of Fosinopril

Sohn CI, Lee OC, Lee KC, Yoo YK, Kim KS, Kim JH, Lim HK, Lee BH, Lee CK

BACKGROUND: Fosinopril is a new phosphorous containing angiotensin converting enzyme inhibitor. To assess the antihypertensive efficacy and safety of fosinopril, the clinical trial was done in patients with mild to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Study of Antihypertensive Effect of Fosinopril in Essential Hypertension

Kang SS, Choi SW, Park KN, Kwak BS, Choi YS, Kim BS, JEon ES, Park CH

BACKGROUND: This study was designed to evaluate the safety and the efficacy of fosinopril(Monopril(R)) in the treatment of mild to moderate essential hypertension. METHOD: Fosinopril(10mg) once a day was administrated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypertensive Efficacy and Safety of Fosinopril in Patients with Mild to Moderate Essential Hypertension

Bae JH, Kang HS, Choue CW, Kim KS, Kim MS, Song JS

BACKGROUND: The efficacy of oral angiotensin converting enzyme(ACE) inhibitors in the treatment of hypertension has been well documented. Fosinopril is a member of a new class of phosphorous containing ACE...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Antihypertensive Efficacy, Safety, and Tolerability of Losartan Versus Fosinopril in Patients with Hypertension

Park DG, Lee MM, Chai IH, Rhee MY, Lee HJ, Kim HS, Kim CH, Sohn DW, Oh BH, Park YB, Choi YS

BACKGROUND: Losartan potassium, an orally active, highly selective AT (1) angiotensin II receptor inhibitor, effectively reduces blood pressure by directly blocking receptors. The purpose of this study is to compare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Study on the Anti-Hypertensive Effect of Fosinopril in Mild to Moderate Hypertensive Patients

Ha JW, Lim SW, Chung N, Shim WH, Cho SY, Kim SS

BACKGROUND: The angiotensin-converting enzyme inhibitors have been found to be safe and efficacious in the treatment of essential hypertension. Fosinopril is the first angiotensin-converting enzyme inhibitor from a new class...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A clinical study on the anti-hypertensive effect of fosinopril in essential hypertensive patients

Nam SY, Cho JH, Shin JH, Kwon HM, Jang YS, Kim HS

In order to investigate the efficacy and safety of oral fosinopril, a new phosphorus containing angiotensin converting enzyme inhibitor, a single dose of 10 to 20mg was administered in 23...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Angiotensin-Converting Enzyme Inhibitor on the Interdialytic Body Weight Gain of Patients on Maintenance Hemodialysis

Kim MK, Yoon TD, Su DD, Lee JY, Kim YK, Lee HG, Kim TY, Choi YS, Kong JM

  • KMID: 2080511
  • Korean J Med.
  • 1997 May;52(5):654-660.
OBJECTIVE: To determine the efficacy of ACE inhibitor on reducing the interdialytic HW gain of patients on maintenance hemodialysis. METHODS: A randomized, double blind, placebo controlled crossover study, consisting of one...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Regression of Left Ventricular Mass in Essential Hypertension

Choi TR, Kim JP, Kang HS, Choue CW, Kim KS, Kim MS, Song JS, Bae JH

BACKGROUND: Hypertension is the most common cause of left ventricular hypertrophy(LVH). Increased left ventricular mass(LVM) carries independent risk for congestive heart failure, coronary artery disease, sudden death, reduction of coronary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Study of the Dry Cough Incidence Rate about Imidapril, the Angiotensin Converting Enzyme Inhibitor

Lee SB, Ko TY, Oh KS, Kwag JS, Chung BS, Yi KR, Choi NH, Lee JY, Kim CS

BACKGROUND AND OBJECTIVES: Imidapril, one of the ACE inhibitor, has been used to treate hypertension, congestive heart failure, diabetes mellitus and renal disease. ACE inhibitor, however often causes dry...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr